190 related articles for article (PubMed ID: 30136330)
1. Treatment with montelukast and antidepressive medication-a symmetry analysis.
Winkel JS; Damkier P; Hallas J; Henriksen DP
Pharmacoepidemiol Drug Saf; 2018 Dec; 27(12):1409-1415. PubMed ID: 30136330
[TBL] [Abstract][Full Text] [Related]
2. Early Discontinuation of Montelukast Treatment; A Danish Nationwide Utilization Study.
Farah RI; Damkier P; Christiansen A; Henriksen DP
Basic Clin Pharmacol Toxicol; 2018 Jul; 123(1):78-83. PubMed ID: 29438596
[TBL] [Abstract][Full Text] [Related]
3. Psychiatric Adverse Effects of Montelukast-A Nationwide Cohort Study.
Jordan A; Toennesen LL; Eklöf J; Sivapalan P; Meteran H; Bønnelykke K; Ulrik CS; Stæhr Jensen JU
J Allergy Clin Immunol Pract; 2023 Jul; 11(7):2096-2103.e1. PubMed ID: 36948487
[TBL] [Abstract][Full Text] [Related]
4. Montelukast use-a 19-year nationwide drug utilisation study.
Henriksen DP; Davidsen JR; Laursen CB; Christiansen A; Damkier P; Hallas J; Pottegård A
Eur J Clin Pharmacol; 2017 Oct; 73(10):1297-1304. PubMed ID: 28639121
[TBL] [Abstract][Full Text] [Related]
5. Antidepressant medication dispensing among montelukast initiators.
Zhou EH; Kaplan S; Mosholder A; Moeny D; Ding Y; Wu Y; Iyasu S; Hammad TA
J Asthma; 2013 Nov; 50(9):990-5. PubMed ID: 23841530
[TBL] [Abstract][Full Text] [Related]
6. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL
Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366
[TBL] [Abstract][Full Text] [Related]
7. Adverse drug reactions affecting treatment adherence in first-line treatment of asthma: An observational study.
Erdem SB; Nacaroglu HT; Can D
Allergol Immunopathol (Madr); 2023; 51(2):11-16. PubMed ID: 36916083
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Neuropsychiatric Diagnoses After Montelukast Initiation.
Paljarvi T; Forton J; Luciano S; Herttua K; Fazel S
JAMA Netw Open; 2022 May; 5(5):e2213643. PubMed ID: 35608857
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of montelukast in adults with asthma and allergic rhinitis.
Virchow JC; Bachert C
Respir Med; 2006 Nov; 100(11):1952-9. PubMed ID: 16626955
[TBL] [Abstract][Full Text] [Related]
10. Roflumilast combined with montelukast versus montelukast alone as add-on treatment in patients with moderate-to-severe asthma.
Bateman ED; Goehring UM; Richard F; Watz H
J Allergy Clin Immunol; 2016 Jul; 138(1):142-149.e8. PubMed ID: 26915674
[TBL] [Abstract][Full Text] [Related]
11. A rare adverse effect of montelukast treatment: ecchymosis.
Aypak C; Türedi Ö; Solmaz N; Yıkılkan H; Görpelioğlu S
Respir Care; 2013 Sep; 58(9):e104-6. PubMed ID: 23322887
[TBL] [Abstract][Full Text] [Related]
12. Montelukast in the treatment of allergic rhinitis: an evidence-based review.
Nayak A; Langdon RB
Drugs; 2007; 67(6):887-901. PubMed ID: 17428106
[TBL] [Abstract][Full Text] [Related]
13. The Risk of Neuropsychiatric Adverse Events With Use of Leukotriene Receptor Antagonists in Patients With Asthma: Analysis of Korea's National Health Insurance Sharing Service Database.
Kim JH; Lee H; Jeong D; Lee JH; Kwon HS; Song WJ; Cho YS; Kim YJ; Shin YW; Kim TB
J Allergy Clin Immunol Pract; 2023 Dec; 11(12):3690-3699.e7. PubMed ID: 37660732
[TBL] [Abstract][Full Text] [Related]
14. A randomized, comparative, multicentric clinical trial to assess the efficacy and safety of zileuton extended-release tablets with montelukast sodium tablets in patients suffering from chronic persistent asthma.
Kubavat AH; Khippal N; Tak S; Rijhwani P; Bhargava S; Patel T; Shah N; Kshatriya RR; Mittal R
Am J Ther; 2013; 20(2):154-62. PubMed ID: 22926233
[TBL] [Abstract][Full Text] [Related]
15. Churg-Strauss syndrome in patients receiving montelukast as treatment for asthma.
Wechsler ME; Finn D; Gunawardena D; Westlake R; Barker A; Haranath SP; Pauwels RA; Kips JC; Drazen JM
Chest; 2000 Mar; 117(3):708-13. PubMed ID: 10712995
[TBL] [Abstract][Full Text] [Related]
16. [Churg-Strauss syndrome after treatment with Singulair (montelukast)].
Hammer HB; Aukrust P; Frøland SS
Tidsskr Nor Laegeforen; 2002 Feb; 122(5):484-6. PubMed ID: 11961976
[TBL] [Abstract][Full Text] [Related]
17. Nationwide cohort study of the leukotriene receptor antagonist montelukast and incident or recurrent cardiovascular disease.
Ingelsson E; Yin L; Bäck M
J Allergy Clin Immunol; 2012 Mar; 129(3):702-707.e2. PubMed ID: 22244598
[TBL] [Abstract][Full Text] [Related]
18. Hallucination development with montelukast in a child with asthma: case presentation.
Kocyigit A; Gulcan Oksuz B; Yarar F; Uzun F; Igde M; Islek I
Iran J Allergy Asthma Immunol; 2013 Aug; 12(4):397-9. PubMed ID: 23996717
[TBL] [Abstract][Full Text] [Related]
19. Montelukast for prevention and treatment of asthma exacerbations in adults: Systematic review and meta-analysis.
Zhang HP; Jia CE; Lv Y; Gibson PG; Wang G
Allergy Asthma Proc; 2014; 35(4):278-87. PubMed ID: 24992547
[TBL] [Abstract][Full Text] [Related]
20. Early patient experiences with montelukast orally disintegrating tablets in Japan: a cross-sectional survey of treatment satisfaction in patients with asthma and/or allergic rhinitis.
Whalley D; Petigara T; Rasouliyan L; Tobe K; Tunceli K
Curr Med Res Opin; 2017 Feb; 33(2):215-223. PubMed ID: 27764975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
